Nintedanib
Overview
Nintedanib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL502835).
API suppliers (5)
Suppliers of Nintedanib evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
5 of 5 hold a GMP certificate on record in the EU or UK registers
- OLON SPAItaly1 active DMF GMP on record
- Formosa Laboratories, Inc.Taiwan1 active DMF GMP on record
- Jiangsu Hansoh Pharmaceutical Group Company LimitedChina1 active DMF GMP on record
- MSN Laboratories Private LimitedIndia1 active DMF GMP on record
- FERMION OYFinland1 active DMF GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (14 approved US products), the latest listed US patent on Nintedanib expires 7 Dec 2029 and exclusivity 6 Mar 2027. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- methyl (3Z)-3-[[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]anilino]-phenylmethylidene]-2-oxo-1H-indole-6-carboxylate
- Canonical SMILES
- CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N/C(=C\3/C4=C(C=C(C=C4)C(=O)OC)NC3=O)/C5=CC=CC=C5
- InChIKey
- XZXHXSATPCNXJR-ZIADKAODSA-N
Do you supply Nintedanib? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.